|
PRPF38A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.002000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.804800E-01 |
| Normal-vs-Stage2 |
2.162400E-01 |
| Normal-vs-Stage3 |
3.820600E-03 |
| Normal-vs-Stage4 |
2.999200E-03 |
| Stage1-vs-Stage2 |
6.702300E-02 |
| Stage1-vs-Stage3 |
1.438350E-04 |
| Stage1-vs-Stage4 |
1.555540E-04 |
| Stage2-vs-Stage3 |
4.718000E-01 |
| Stage2-vs-Stage4 |
4.097000E-01 |
| Stage3-vs-Stage4 |
8.029200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.705240E-01 |
| Normal-vs-AfricanAmerican |
6.183600E-01 |
| Normal-vs-Asian |
4.824400E-01 |
| Caucasian-vs-AfricanAmerican |
8.860800E-01 |
| Caucasian-vs-Asian |
4.197000E-01 |
| AfricanAmerican-vs-Asian |
5.788600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.441540E-02 |
| Normal-vs-Female |
3.326400E-01 |
| Male-vs-Female |
4.783100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.174000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.361600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.021800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.646240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.780000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.306200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.118600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.225400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.531000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.312600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.398140E-02 |
| Normal-vs-Grade 2 |
7.351600E-02 |
| Normal-vs-Grade 3 |
1.296060E-03 |
| Normal-vs-Grade 4 |
1.51039999995994E-06 |
| Grade 1-vs-Grade 2 |
1.801820E-02 |
| Grade 1-vs-Grade 3 |
1.627900000023E-06 |
| Grade 1-vs-Grade 4 |
6.42470000533635E-08 |
| Grade 2-vs-Grade 3 |
1.08119999953082E-07 |
| Grade 2-vs-Grade 4 |
5.17540010847028E-10 |
| Grade 3-vs-Grade 4 |
2.366200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.846000E-04 |
| Normal-vs-ccB subtype |
9.30090000017536E-07 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.568770E-01 |
| Normal-vs-N1 |
2.221300E-03 |
| N0-vs-N1 |
1.064230E-01 |
|
|
